Small molecule drug candidate offers hope for rare kidney stone disease with no current treatment

Scientists at Buck Institute developed N-propargylglycine (N-PPG), a small molecule drug that completely prevents kidney stone formation and restores normal survival in mice with primary hyperoxaluria type 2 (PH2), a rare genetic disorder affecting ~